Skip to main content
. 2022 Jun 17;15:3573–3586. doi: 10.2147/JIR.S361300

Table 2.

Associations Between Indicators and OS in All Females with Cancer

Characteristics Model 1a P value Model 2b P value Model 3c P value
HR (95% CI) HR (95% CI) HR (95% CI)
ALI
 Continuousd 0.64 (0.57, 0.72) < 0.001 0.77 (0.68, 0.87) < 0.001 0.83 (0.73, 0.94) 0.004
 Highd 0.38 (0.32, 0.45) < 0.001 0.55 (0.45, 0.67) < 0.001 0.62 (0.51, 0.77) < 0.001
 Quartile 2d 0.53 (0.42, 0.66) < 0.001 0.67 (0.53, 0.85) 0.001 0.71 (0.56, 0.91) 0.006
 Quartile 3d 0.38 (0.30, 0.48) < 0.001 0.55 (0.43, 0.72) < 0.001 0.65 (0.49, 0.86) 0.002
 Quartile 4d 0.27 (0.20, 0.35) < 0.001 0.42 (0.31, 0.56) < 0.001 0.50 (0.36, 0.69) < 0.001
P for trend 0.64 (0.59, 0.69) < 0.001 0.75 (0.68, 0.82) < 0.001 0.80 (0.72, 0.88) < 0.001
SII
 Continuousd 1.35 (1.27, 1.44) < 0.001 1.23 (1.14, 1.32) < 0.001 1.18 (1.09, 1.27) < 0.001
 Highe 2.51 (2.10, 3.01) < 0.001 1.92 (1.59, 2.33) < 0.001 1.72 (1.41, 2.10) < 0.001
 Quartile 2e 1.27 (0.96, 1.68) 0.093 1.33 (0.99, 1.79) 0.062 1.29 (0.95, 1.74) 0.097
 Quartile 3e 1.20 (0.90, 1.60) 0.213 1.06 (0.78, 1.43) 0.731 0.95 (0.69, 1.29) 0.729
 Quartile 4e 2.88 (2.23, 3.71) < 0.001 2.12 (1.61, 2.79) < 0.001 1.78 (1.34, 2.38) < 0.001
P for trend 1.42 (1.30, 1.54) < 0.001 1.26 (1.15, 1.37) < 0.001 1.18 (1.08, 1.30) < 0.001
mGNRI
 Continuousd 0.64 (0.57, 0.72) < 0.001 0.76 (0.66, 0.88) < 0.001 0.80 (0.69, 0.92) 0.002
 Highf 0.46 (0.38, 0.55) < 0.001 0.54 (0.42, 0.69) < 0.001 0.59 (0.46, 0.76) < 0.001
 Quartile 2f 0.64 (0.51, 0.81) < 0.001 0.61 (0.46, 0.8) < 0.001 0.64 (0.49, 0.84) 0.001
 Quartile 3f 0.48 (0.38, 0.61) < 0.001 0.42 (0.30, 0.59) < 0.001 0.47 (0.34, 0.67) < 0.001
 Quartile 4f 0.29 (0.22, 0.38) < 0.001 0.34 (0.22, 0.51) < 0.001 0.40 (0.27, 0.60) < 0.001
P for trend 0.67 (0.62, 0.73) < 0.001 0.69 (0.6, 0.79) < 0.001 0.73 (0.64, 0.84) < 0.001
AGR
 Continuesd 0.66 (0.60, 0.73) < 0.001 0.75 (0.68, 0.83) < 0.001 0.78 (0.70, 0.86) < 0.001
 Highg 0.47 (0.39, 0.56) < 0.001 0.60 (0.50, 0.73) < 0.001 0.63 (0.52, 0.76) < 0.001
 Quartile 2g 0.74 (0.59, 0.92) 0.008 0.80 (0.63, 1.02) 0.07 0.87 (0.68, 1.11) 0.257
 Quartile 3g 0.48 (0.38, 0.62) < 0.001 0.55 (0.42, 0.72) < 0.001 0.59 (0.45, 0.78) < 0.001
 Quartile 4g 0.37 (0.29, 0.48) < 0.001 0.54 (0.41, 0.70) < 0.001 0.57 (0.44, 0.76) < 0.001
P for trend 0.71 (0.66, 0.77) < 0.001 0.79 (0.73, 0.87) < 0.001 0.81 (0.74, 0.89) < 0.001
PNI
 Continuousd 0.65 (0.60, 0.71) < 0.001 0.76 (0.69, 0.83) < 0.001 0.79 (0.72, 0.87) < 0.001
 Highh 0.44 (0.36, 0.53) < 0.001 0.61 (0.50, 0.76) < 0.001 0.66 (0.53, 0.82) < 0.001
 Quartile 2h 0.59 (0.47, 0.74) < 0.001 0.66 (0.52, 0.84) 0.001 0.70 (0.55, 0.89) 0.004
 Quartile 3h 0.46 (0.36, 0.59) < 0.001 0.64 (0.5, 0.83) 0.001 0.71 (0.55, 0.93) 0.013
 Quartile 4h 0.31 (0.24, 0.41) < 0.001 0.48 (0.37, 0.64) < 0.001 0.53 (0.40, 0.71) < 0.001
P for trend 0.68 (0.63, 0.74) < 0.001 0.80 (0.73, 0.87) < 0.001 0.83 (0.75, 0.90) < 0.001
LCR
 Continuousd 0.62 (0.51, 0.75) < 0.001 0.76 (0.64, 0.91) 0.002 0.81 (0.68, 0.96) 0.013
 Highi 0.38 (0.32, 0.45) < 0.001 0.55 (0.45, 0.66) < 0.001 0.61 (0.50, 0.74) < 0.001
 Quartile 2i 0.66 (0.53, 0.82) < 0.001 0.82 (0.65, 1.04) 0.103 0.87 (0.69, 1.11) 0.268
 Quartile 3i 0.39 (0.30, 0.50) < 0.001 0.55 (0.43, 0.71) < 0.001 0.61 (0.47, 0.80) < 0.001
 Quartile 4i 0.24 (0.19, 0.32) < 0.001 0.43 (0.32, 0.58) < 0.001 0.49 (0.36, 0.66) < 0.001
P for trend 0.62 (0.57, 0.68) < 0.001 0.75 (0.68, 0.82) < 0.001 0.78 (0.71, 0.86) < 0.001
CONUT
 Lightj 1.42 (1.13, 1.80) 0.003 1.19 (0.93, 1.52) 0.176 1.18 (0.92, 1.52) 0.193
 Moderatej 2.82 (2.08, 3.83) < 0.001 2.24 (1.62, 3.11) < 0.001 2.00 (1.42, 2.83) < 0.001
 Severej 3.27 (1.65, 6.48) 0.001 2.36 (1.02, 5.44) 0.045 2.18 (0.93, 5.09) 0.073
P for trend 1.20 (1.15, 1.25) < 0.001 1.44 (1.23, 1.69) < 0.001 1.11 (1.06, 1.17) < 0.001
mGPS
 1 1.83 (1.45, 2.32) < 0.001 1.25 (0.98, 1.61) 0.076 1.21 (0.94, 1.55) 0.146
 2 3.30 (2.61, 4.18) < 0.001 2.19 (1.70, 2.82) < 0.001 1.89 (1.45, 2.47) < 0.001
P for trend 1.82 (1.62, 2.04) < 0.001 1.44 (1.27, 1.64) < 0.001 1.35 (1.18, 1.54) < 0.001
LCS
 1 2.59 (1.98, 3.38) < 0.001 1.70 (1.28, 2.27) < 0.001 1.57 (1.18, 2.09) 0.002
 2 5.26 (3.85, 7.20) < 0.001 2.66 (1.9, 3.72) < 0.001 2.35 (1.66, 3.31) < 0.001
P for trend 2.26 (1.94, 2.62) < 0.001 1.62 (1.38, 1.9) < 0.001 1.53 (1.29, 1.81) < 0.001

Notes: aModel 1 was not adjusted for any covariates. bModel 2 was adjusted for age, body mass index, type of cancer, smoking status, alcohol consumption and TNM stage. cModel 3 was adjusted for age, body mass index, type of cancer, smoking status, alcohol consumption, TNM stage, history of surgery, radiotherapy and chemotherapy, Karnofsky performance status score and Scored Patient-Generated Subjective Global Assessment. dContinuous: as continuous variable; Low: < 23.727; High: ≥ 23.727; Quartile 1: < 22.875; Quartile 2: 22.875 ~ < 38.805; Quartile 3: 38.805 ~ < 61.579; Quartile 4: ≥ 61.579. eContinuous: as continuous variable; Low: < 930.286; High: ≥ 930.286; Quartile 1: < 317.797; Quartile 2: 317.797 ~ < 533.433; Quartile 3: 533.433 ~ < 929.343; Quartile 4: ≥ 929.343. fContinuous: as continuous variable; Low: < 46.858; High: ≥ 46.858; Quartile 1: < 42.460; Quartile 2: 42.460 ~ < 47.856; Quartile 3: 47.856 ~ < 55.432; Quartile 4: ≥ 55.432. gContinuous: as continuous variable; Low: < 1.232; High: ≥ 1.232; Quartile 1: < 1.173; Quartile 2: 1.173 ~ < 1.354; Quartile 3: 1.354 ~ < 1.546; Quartile 4: ≥ 1.546. hContinuous: as continuous variable; Low: < 48.700; High: ≥ 48.700; Quartile 1: < 43.600; Quartile 2: 43.600 ~ < 47.450; Quartile 3: 47.450 ~ < 51.350; Quartile 4: ≥ 51.350. iContinuous: as continuous variable; Low: < 3212.291; High: ≥ 3212.291; Quartile 1: < 1297.710; Quartile 2: 1297.710 ~ < 4134.754; Quartile 3: 4134.754 ~ < 7399.381; Quartile 4: ≥ 7399.381. jNormal: 0–1; Light: 2–4; Moderate: 5–8; Severe: 9–12.

Abbreviations: OS, overall survival; HR, hazard ratio; CI, confidence interval; Alb, serum albumin; Glb, serum globulin; CRP, C-reactive protein; Lym, lymphocyte; ALI, advanced lung cancer inflammation index; SII, systemic immune inflammation index; mGNRI, modified geriatric nutritional risk index; AGR, Alb-to-Glb ratio; PNI, prognostic nutritional index; LCR, Lym-to-CRP ratio; CONUT, controlling nutritional status score; mGPS, modified Glasgow prognostic score; LCS, Lym-to-CRP score.